These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 10933969

  • 1. A modular set of helper-dependent herpes simplex virus expression vectors.
    Strathdee CA, McLeod MR.
    Mol Ther; 2000 May; 1(5 Pt 1):479-85. PubMed ID: 10933969
    [Abstract] [Full Text] [Related]

  • 2. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA.
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [Abstract] [Full Text] [Related]

  • 3. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H, Fournel S, Epstein AL.
    Virology; 1996 Feb 15; 216(2):437-43. PubMed ID: 8607275
    [Abstract] [Full Text] [Related]

  • 4. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O, Glauser DL, Fraefel C.
    Cold Spring Harb Protoc; 2012 Mar 01; 2012(3):352-6. PubMed ID: 22383640
    [Abstract] [Full Text] [Related]

  • 5. Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.
    Frenkel N, Singer O, Kwong AD.
    Gene Ther; 1994 Mar 01; 1 Suppl 1():S40-6. PubMed ID: 8542394
    [Abstract] [Full Text] [Related]

  • 6. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
    Sia KC, Wang GY, Ho IA, Khor HY, Miao L, Hui KM, Lam PY.
    J Virol Methods; 2007 Feb 01; 139(2):166-74. PubMed ID: 17074404
    [Abstract] [Full Text] [Related]

  • 7. Delivery of herpes simplex virus vectors through liposome formulation.
    Fu X, Zhang X.
    Mol Ther; 2001 Nov 01; 4(5):447-53. PubMed ID: 11708881
    [Abstract] [Full Text] [Related]

  • 8. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
    Sena-Esteves M, Hampl JA, Camp SM, Breakefield XO.
    J Gene Med; 2002 Nov 01; 4(3):229-39. PubMed ID: 12112640
    [Abstract] [Full Text] [Related]

  • 9. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
    Yang T, Wang X, Yan Z, Hou Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec 01; 11(4):306-10. PubMed ID: 15617234
    [Abstract] [Full Text] [Related]

  • 10. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
    Sun M, Lee J, Yu L, Geller AI.
    Acta Virol; 2000 Dec 01; 44(6):365-9. PubMed ID: 11332280
    [Abstract] [Full Text] [Related]

  • 11. Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus.
    Tzeng WP, Chen MH, Derdeyn CA, Frey TK.
    Virology; 2001 Oct 10; 289(1):63-73. PubMed ID: 11601918
    [Abstract] [Full Text] [Related]

  • 12. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F, Hartley D, Starr P, Lang P, Song S, Yu L, Wang Y, Geller AI.
    Biotechniques; 1996 Mar 10; 20(3):460-9. PubMed ID: 8679207
    [Abstract] [Full Text] [Related]

  • 13. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 14. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
    Geller AI, Yu L, Wang Y, Fraefel C.
    Exp Neurol; 1997 Mar 01; 144(1):98-102. PubMed ID: 9126158
    [Abstract] [Full Text] [Related]

  • 15. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
    Stavropoulos TA, Strathdee CA.
    J Virol; 1998 Sep 01; 72(9):7137-43. PubMed ID: 9696807
    [Abstract] [Full Text] [Related]

  • 16. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
    Logvinoff C, Epstein AL.
    Hum Gene Ther; 2001 Jan 20; 12(2):161-7. PubMed ID: 11177553
    [Abstract] [Full Text] [Related]

  • 17. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
    Zibert A, Thomassen A, Müller L, Nguyen L, Glouchkova L, Fraefel C, Roskrow M, Meisel R, Dilloo D.
    Gene Ther; 2005 Dec 20; 12(23):1707-17. PubMed ID: 16034459
    [Abstract] [Full Text] [Related]

  • 18. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A, Cortés ML, Perry KF, Sena-Esteves M, Fraefel C, Breakefield XO.
    Gene Ther; 2007 Jul 20; 14(14):1078-91. PubMed ID: 17460718
    [Abstract] [Full Text] [Related]

  • 19. Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.
    Sia KC, Chong WK, Ho IA, Yulyana Y, Endaya B, Huynh H, Lam PY.
    J Gene Med; 2010 Oct 20; 12(10):848-58. PubMed ID: 20963807
    [Abstract] [Full Text] [Related]

  • 20. Analysis of two potential shuttle vectors containing herpes simplex virus defective DNA.
    Bear SE, Colberg-Poley AM, Court DL, Carter BJ, Enquist LW.
    J Mol Appl Genet; 1984 Oct 20; 2(5):471-84. PubMed ID: 6090565
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.